183
Participants
Start Date
August 31, 2011
Primary Completion Date
May 31, 2012
Study Completion Date
August 31, 2012
CKD-828 40/2.5mg
Fixed dose combination of Telmisartan 40mg and S-Amlodipine 2.5mg
CKD-828 40/5mg
Fixed dose combination of Telmisartan 40mg and S-Amlidioine 5mg
Telmisartan 80mg
Telmisartan 80mg monotherapy
Kandong Sacred Heart Hospital, Anyang
Daegu Catholic University Medical Center, Daegu
Keimyung University Dongsan Medical Center, Daegu
DonGuk University Ilsan Hospital, Goyang
National Health Insurance Corporation Ilsan Hospital, Goyang
Gachon University Gil Medical Center, Inchon
Chonbuk National University Hospital, Jeonju
Seoul National University Bundang Hospital, Seongnam
Bundang Cha Medical Center, Seoul
Ewha Womans University Hospital, Seoul
Gangnam Severance Hospital, Seoul
Inje University Ilsan Paik Hospital, Seoul
Korea University Guro Hospital, Seoul
Kyung Hee University Medical Center, Seoul
Severance Hospital, Seoul
Soon Chun Hyang University Hospital, Seoul
St. Paul's Hospital, The catholic University of Korea, Seoul
Ajou University Hospital, Suwon
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY